Robert Neville
2017
In 2017, Robert Neville earned a total compensation of $600.2K as Chief Executive Officer at Mast Therapeutics.
Compensation breakdown
| Bonus | $276,750 |
|---|---|
| Non-Equity Incentive Plan | $90,750 |
| Salary | $210,938 |
| Other | $21,750 |
| Total | $600,188 |
Neville received $276.8K in bonus, accounting for 46% of the total pay in 2017.
Neville also received $90.8K in non-equity incentive plan, $210.9K in salary and $21.8K in other compensation.
Rankings
In 2017, Robert Neville's compensation ranked 11,196th out of 14,666 executives tracked by ExecPay. In other words, Neville earned more than 23.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,196 out of 14,666 | 24th |
Division Manufacturing | 4,382 out of 5,768 | 24th |
Major group Chemicals And Allied Products | 1,588 out of 2,074 | 23rd |
Industry group Drugs | 1,307 out of 1,730 | 25th |
Industry Pharmaceutical Preparations | 1,020 out of 1,329 | 23rd |
Source: SEC filing on April 23, 2018.
Neville's colleagues
We found six more compensation records of executives who worked with Robert Neville at Mast Therapeutics in 2017.
2017
Brian Culley
Mast Therapeutics
Chief Executive Officer
2017
Edwin Parsley
Mast Therapeutics
Former Chief Medical Office & Senior Vice President
2017
Brandi Roberts
Mast Therapeutics
Chief Financial Officer
2017
Taneli Jouhikainen
Mast Therapeutics
Chief Operating Officer
2017
Shana Hood
Mast Therapeutics
General Counsel
2017
Dave Lowrance
Mast Therapeutics